An article 2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson’s Disease WOS:000588899700001 published article about NF-KAPPA-B; 2-HYDROXY-4-TRIFLUOROMETHYLBENZOIC ACID; MOUSE MODEL; MICROGLIA; INFLAMMATION; NEURODEGENERATION; TRIFLUSAL; ACTIVATION; NEUROTOXICITY; METABOLITE in [Song, Soo-Yeol; Kim, In-Su; Koppula, Sushruta; Kim, Byung-Wook; Choi, Dong-Kug] Konkuk Univ, Dept Biotechnol, Chungju 380701, South Korea; [Park, Ju-Young; Yoon, Sung-Hwa] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea in 2020, Cited 45. Recommanded Product: 93-97-0. The Name is Benzoic anhydride. Through research, I have a further understanding and discovery of 93-97-0
Microglia-mediated neuroinflammation is one of the key mechanisms involved in acute brain injury and chronic neurodegeneration. This study investigated the inhibitory effects of 2-hydroxy-4-methylbenzoic anhydride (HMA), a novel synthetic derivative of HTB (3-hydroxy-4-trifluoromethylbenzoic acid) on neuroinflammation and underlying mechanisms in activated microglia in vitro and an in vivo mouse model of Parkinson’s disease (PD). In vitro studies revealed that HMA significantly inhibited lipopolysaccharide (LPS)-stimulated excessive release of nitric oxide (NO) in a concentration dependent manner. In addition, HMA significantly suppressed both inducible NO synthase and cyclooxygenase-2 (COX-2) at the mRNA and protein levels in LPS-stimulated BV-2 microglia cells. Moreover, HMA significantly inhibited the proinflammatory cytokines such as interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha in LPS-stimulated BV-2 microglial cells. Furthermore, mechanistic studies ensured that the potent anti-neuroinflammatory effects of HMA (0.1, 1.0, and 10 mu M) were mediated by phosphorylation of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (I kappa B alpha) in LPS-stimulated BV-2 cells. In vivo evaluations revealed that intraperitoneal administration of potent neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 20 mg/kg, four times a 1 day) in mice resulted in activation of microglia in the brain in association with severe behavioral deficits as assessed using a pole test. However, prevention of microglial activation and attenuation of Parkinson’s disease (PD)-like behavioral changes was obtained by oral administration of HMA (30 mg/kg) for 14 days. Considering the overall results, our study showed that HMA exhibited strong anti-neuroinflammatory effects at lower concentrations than its parent compound. Further work is warranted in other animal and genetic models of PD for evaluating the efficacy of HMA to develop a potential therapeutic agent in the treatment of microglia-mediated neuroinflammatory disorders, including PD.
Recommanded Product: 93-97-0. Welcome to talk about 93-97-0, If you have any questions, you can contact Song, SY; Kim, IS; Koppula, S; Park, JY; Kim, BW; Yoon, SH; Choi, DK or send Email.
Reference:
Isothiazole – Wikipedia,
,Isothiazole – ScienceDirect.com